Torchilin Vladimir P
Department of Pharmaceutical Sciences, Northeastern University, Boston, MA 02115, USA.
Curr Drug Deliv. 2005 Oct;2(4):319-27. doi: 10.2174/156720105774370221.
Micelles, self-assembling nanosized colloidal particles with a hydrophobic core and hydrophilic shell are currently successfully used for the solubilization of various poorly soluble pharmaceuticals and demonstrate a series of attractive properties as drug carriers. Polymeric micelles, i.e. micelles formed by amphiphilic block co-polymers possess high stability both in vitro and in vivo and good biocompatibility. Among those micelles, lipid-core micelles, i.e. micelles formed by conjugates of soluble copolymers with lipids (such as polyethylene glycol-phosphatidyl ethanolamine conjugate, PEG-PE) are of special interest. These micelles can effectively solubilize a broad variety of poorly soluble drugs (anticancer drugs in particular) and diagnostic agents. Drug-loaded lipid-core micelles can spontaneously target body areas with compromised vasculature (tumors, infarcts) via the enhanced permeability and retention (EPR) effect. Lipid-core mixed micelles containing certain specific components (such as positively charged lipids) are capable of escaping endosomes delivering incorporated drugs directly into the cell cytoplasm. Various specific targeting ligand molecules (such as antibodies) can be attached to the surface of the lipid-core micelles and bring drug-loaded micelles to and into target cells. Lipid-core micelles carrying various reporter (contrast) groups may become the imaging agents of choice in different imaging modalities.
胶束是具有疏水核心和亲水外壳的自组装纳米级胶体颗粒,目前已成功用于增溶各种难溶性药物,并作为药物载体展现出一系列吸引人的特性。聚合物胶束,即由两亲性嵌段共聚物形成的胶束,在体外和体内均具有高稳定性以及良好的生物相容性。在这些胶束中,脂质核心胶束,即由可溶性共聚物与脂质的缀合物(如聚乙二醇 - 磷脂酰乙醇胺缀合物,PEG - PE)形成的胶束,特别受关注。这些胶束能够有效增溶多种难溶性药物(尤其是抗癌药物)和诊断剂。载药脂质核心胶束可通过增强的渗透和滞留(EPR)效应自发靶向血管受损的身体部位(肿瘤、梗死灶)。含有某些特定成分(如带正电荷的脂质)的脂质核心混合胶束能够逃离内体,将包封的药物直接递送至细胞质中。各种特定的靶向配体分子(如抗体)可连接到脂质核心胶束的表面,并将载药胶束带到靶细胞并进入靶细胞。携带各种报告(造影)基团的脂质核心胶束可能成为不同成像模式中首选的成像剂。
Curr Drug Deliv. 2005-10
Pharm Res. 2007-1
Cell Mol Life Sci. 2004-10
Adv Drug Deliv Rev. 2004-5-7
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015
J Control Release. 2001-6-15
Life (Basel). 2021-7-13
J Control Release. 2020-10-10